Skip to content
Screener

Total Current Assets at other companies

IAR
Integra LifeSciencesIART
$1.19B+4.3%
MiMedx Group logo
MiMedx GroupMDXG
$205.37M-7.0%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$23.2M+15.0%
Axogen logo
AxogenAXGN
$200.38M+93.8%
Anika Therapeutics logo
Anika TherapeuticsANIK
$99.19M-0.1%
Solventum logo
SolventumSOLV
$3.74B+16.6%

Other financials

Income statement

See full
Revenue$43.8M-56.7%
Gross profit$63.0M-22.5%
Operating income-$51.0M-305%
Net income-$96.3M-925%
EPS (diluted)-$0.77-670%

Balance sheet

See full
Cash & equivalents$46.1M-36.9%
Total debt$36.6M+19.2%
Total equity$148.3M-36.4%
Total assets$406.4M-11.9%

Cash flow

See full
Operating cash flow-$31.7M+3.7%
CapEx$1.1M-69.8%
Free cash flow-$32.8M+10.3%

Valuation

See full
Market cap$239.33M-59.1%
Enterprise value$229.8M-57.7%
P/S0.5×-0.8×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin-7.8%
Net margin-18.4%-20.8pp
FCF margin6.9%

Returns & leverage

See full
Return on equity-44.1%-48.0pp
Debt / equity0.2×+0.1×
Current ratio3.5×-0.4×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338049
Line itemJune 30, 2026December 31, 2025
Inventories, net29,28029,627
Asset held for sale3,6132,425
Prepaid expenses and other current assets19,62818,354
Total current assets200,302362,188
Property and equipment, net101,531103,711
Intangible assets, net3,0049,145
Goodwill28,77228,772
Operating lease right-of-use assets, net49,91255,749

Item 1. Unaudited Condensed Consolidated Financial Statements.

FAQ

What is Organogenesis Holdings Inc.'s total current assets?
Organogenesis Holdings Inc. (ORGO) reported total current assets of $200.3M in Q2 2026.
How has Organogenesis Holdings Inc.'s total current assets changed year-over-year?
Organogenesis Holdings Inc.'s total current assets decreased by 23.0% year-over-year, from $260.22M to $200.3M.
What is the long-term trend for Organogenesis Holdings Inc.'s total current assets?
Over 5 years (2020 to 2025), Organogenesis Holdings Inc.'s total current assets has grown at a 15.7% compound annual growth rate (CAGR), from $174.34M to $362.19M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Organogenesis Holdings Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude